Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Testosterone Cypionate in Hypogonadal Men with Ambulatory Blood Pressure Monitoring
NCT07328542Phase 4Not yet recruiting
- Sponsor
- Azurity Pharmaceuticals
- Start
- Feb 2026
- Primary completion
- Jun 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of testosterone cypionate in Hypogonadism, sponsored by Azurity Pharmaceuticals. Planned start Feb 2026; status: not yet recruiting.
02
Drugs
testosterone cypionate
03
Conditions
Hypogonadism
Beyond the preview
Go deeper on NCT07328542.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07328542.